Skip to main content

Abstract

Brain activation differences during emotional processing between elderly patients with and without major depressive disorder were greater for depressed patients with more white matter lesions.

Abstract

Objective:

This study tests whether or not the structural white matter lesions that are characteristic of late-life depression are associated with alterations in the functional affective circuits of late-life depression. This study used an emotional faces paradigm that has been shown to engage the affective limbic brain regions.

Method:

Thirty-three elderly depressed patients and 27 nondepressed comparison subjects participated in this study. The patients were recruited through the NIMH-sponsored Advanced Center for Interventions and Services Research for the Study of Late-Life Mood Disorders at the University of Pittsburgh Center for Bioethics and Health Law. Structural and functional MRI was used to assess white matter hyperintensity (WMH) burden and functional magnetic resonance imaging (fMRI) blood-oxygen-level-dependent (BOLD) response on a facial expression affective-reactivity task in both elderly participants with nonpsychotic and nonbipolar major depression (unmedicated) and nondepressed elderly comparison subjects.

Results:

As expected, greater subgenual cingulate activity was observed in the depressed patients relative to the nondepressed comparison subjects. This same region showed greater task-related activity associated with a greater burden of cerebrovascular white matter change in the depressed group. Moreover, the depressed group showed a significantly greater interaction of WMH by fMRI activity effect than the nondepressed group.

Conclusions:

The observation that high WMH burden in late-life depression is associated with greater BOLD response on the affective-reactivity task supports the model that white matter ischemia in elderly depressed patients disrupts brain mechanisms of affective regulation and leads to limbic hyperactivation.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1075 - 1082
PubMed: 21799066

History

Received: 16 June 2010
Revision received: 23 December 2010
Revision received: 18 March 2011
Accepted: 23 March 2011
Published online: 1 October 2011
Published in print: October 2011

Authors

Affiliations

Howard J. Aizenstein, M.D., Ph.D.
From the Departments of Psychiatry, Bioengineering, Neurology, Neuroscience, and Radiology at the University of Pittsburgh, Pittsburgh.
Carmen Andreescu, M.D.
From the Departments of Psychiatry, Bioengineering, Neurology, Neuroscience, and Radiology at the University of Pittsburgh, Pittsburgh.
Kathryn L. Edelman, B.A.
From the Departments of Psychiatry, Bioengineering, Neurology, Neuroscience, and Radiology at the University of Pittsburgh, Pittsburgh.
Jennifer L. Cochran, Ph.D.
From the Departments of Psychiatry, Bioengineering, Neurology, Neuroscience, and Radiology at the University of Pittsburgh, Pittsburgh.
Julie Price, Ph.D.
From the Departments of Psychiatry, Bioengineering, Neurology, Neuroscience, and Radiology at the University of Pittsburgh, Pittsburgh.
Meryl A. Butters, Ph.D.
From the Departments of Psychiatry, Bioengineering, Neurology, Neuroscience, and Radiology at the University of Pittsburgh, Pittsburgh.
Jordan Karp, M.D.
From the Departments of Psychiatry, Bioengineering, Neurology, Neuroscience, and Radiology at the University of Pittsburgh, Pittsburgh.
Meenal Patel, B.S.
From the Departments of Psychiatry, Bioengineering, Neurology, Neuroscience, and Radiology at the University of Pittsburgh, Pittsburgh.
Charles F. Reynolds, III, M.D.
From the Departments of Psychiatry, Bioengineering, Neurology, Neuroscience, and Radiology at the University of Pittsburgh, Pittsburgh.

Notes

Address correspondence to Dr. Aizenstein ([email protected]).

Funding Information

The authors report no financial relationships with commercial interests.Supported by NIMH grants R01-MH076079, MH086686, KL2 RR024154, and P30-MH52247/P30-MH71944, the NARSAD Young Investigator Award (C.A.), and the John A. Hartford Center of Excellence in Geriatric Psychiatry at the University of Pittsburgh. Forest Pharmaceuticals and Eli Lilly donated antidepressant medications for this study.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share